Tower Research Capital »

Sonnet Biotherapeutc Hldng I shares owned by Tower Research Capital

Quarter-by-quarter ownership of Sonnet Biotherapeutc Hldng I (SONN) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Sonnet Biotherapeutc Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Sonnet Biotherapeutc Hldng I held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sonnet Biotherapeutc Hldng I by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $6.7k 7.2k 0.94
2024-03-31 $5.1k 2.7k 1.86

More positions owned by Tower Research Capital

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Costco Wholesale Corporation (COST)
Netflix (NFLX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Adobe Systems Incorporated (ADBE)

View all positions for Tower Research Capital

Top funds holding Sonnet Biotherapeutc Hldng I

Armistice Capital
Vanguard Group
Tower Research Capital
BlackRock
Morgan Stanley

View all funds holding Sonnet Biotherapeutc Hldng I